Review anchor
Adhesion G-protein coupled receptor F1
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
Evidence Snapshot
Adhesion G-protein coupled receptor F1
CHEMBL4523872
SINGLE PROTEIN
Homo sapiens
Identity Layer
Cross-source identity
Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.
This review treats Adhesion G-protein coupled receptor F1 as ChEMBL target CHEMBL4523872, mapped to UniProt Q5T601. Disease framing currently uses the Open Targets-ready proxy contract.
ChEMBL target ID
CHEMBL4523872
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine
As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q5T601
Adhesion G-protein coupled receptor F1
UniProt accession via ChEMBL component mapping
As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy
As of 2026-09-13
www.ebi.ac.uk
Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.
Review-ready Target Rationale
Why Adhesion G-protein coupled receptor F1 matters
Adhesion G-protein coupled receptor F1 is reviewed as Adhesion G-protein coupled receptor F1 (UniProt Q5T601); the current evidence base includes 2 approved drugs, 439 compounds, and 7 assays, with lead potency reaching pChEMBL 5.7.
Protein context
Adhesion G-protein coupled receptor F1
Adhesion G-protein coupled receptor F1 Sequence length is 910 aa.
Review this target as Adhesion G-protein coupled receptor F1, mapped to UniProt Q5T601. Sequence length is 910 aa.
Protein source · UniProt accession via ChEMBL component mapping
UniProt Q5T601
Protein
Disease context
Disease signal
Disease relevance is not yet populated for this evidence card.
This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.
ChEMBL target recordActivity base
Portfolio and assay base
ChEMBL currently tracks 2 approved drugs, 439 compounds, and 7 assays for this target. The dominant activity type is IC50. CHEMBL484929 is the current potency anchor at pChEMBL 5.7.
Use CHEMBL484929 as the tractability anchor when discussing potency (pChEMBL 5.7).
Activity source · ChEMBL 36 via Core Engine
2 approved
pChEMBL 5.7
Source Guidance
Start with the right source
Pick the first block or linked source that matches the review question in front of you.
Need the shortest review narrative first?
Review-ready Target Rationale
One-page rationale with as-of-date and attribution
Start with the review rationale when you need to explain why Adhesion G-protein coupled receptor F1 matters before drilling into raw source blocks.
Jump to Review RationaleNeed stable protein naming or accession mapping?
UniProt Target Context
UniProt accession via ChEMBL component mapping
Go back to the target snapshot when you need the naming and mapping contract behind UniProt Q5T601, not just the summarized rationale.
Open Protein ContextNeed disease fit or evidence level for program framing?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy
Use the target snapshot disease block when you need the disease program and supporting signals, not only the card summary.
Open Disease ContextSnapshot State
No project snapshot selected. Export uses the live evidence card state.
439
Total Compounds
7
Total Assays
2
Approved Drugs
IC50: 18.0, EC50: 8.0
Activity Types
pChEMBL Activity Distribution
Top 5 Inhibitors (by pChEMBL)
| Structure | Compound | pChEMBL | Type | Phase |
|---|---|---|---|---|
|
|
No preferred name
CHEMBL484929
|
5.7 | EC50 | — |
|
|
No preferred name
CHEMBL1707
|
5.7 | EC50 | Approved |
|
|
No preferred name
CHEMBL5092226
|
5.7 | IC50 | — |
|
|
No preferred name
CHEMBL1256876
|
5.6 | IC50 | — |
|
|
No preferred name
CHEMBL531742
|
5.5 | IC50 | — |
Source Header